Overview
- 5 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
7 Mar 2011
21 CFR 111.103
Written procedures - quality control operations
Cited by Marcus F Yambot, Julia Ventura
7 Mar 2011
21 CFR 111.105(i)
QC required operations production and process control
Cited by Marcus F Yambot, Julia Ventura
7 Mar 2011
21 CFR 111.105(i)
Quality control - required operations product complaints
Cited by Marcus F Yambot, Julia Ventura
7 Mar 2011
21 CFR 111.315(b)(5)
Sampling plans; packaged, labeled dietary supplement, QC
Cited by Marcus F Yambot, Julia Ventura
7 Mar 2011
21 CFR 111.570(b)(1)
Written procedures - product complaint; review, investigate
Cited by Marcus F Yambot, Julia Ventura
Inspected site
GPGlobal Product Management, Inc.Monrovia, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.105(i) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.315(b)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.570(b)(1) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere